EBV LMP1 anticorps (C-Term)
Aperçu rapide pour EBV LMP1 anticorps (C-Term) (ABIN956940)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Immunogène
- Peptide derived from the C-terminal region of Epstein-Barr virus, Latent Membrane Protein-1
-
-
-
-
Indications d'application
-
Approved: IHC, IHC-Fr, IHC-P (1:100 - 1:200)
Usage: Centrifuge the vial before use. -
Commentaires
-
Target Species of Antibody: Epstein-Barr Virus
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 20 mM Tris-HCl, pH 8.0, 20 mg/mL BSA stabilzer, 0.05 % 0.05 % Sodium azide preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- avoid freezing
-
Stock
- 4 °C
-
Stockage commentaire
- 4°C, avoid freezing.
-
-
- EBV LMP1 (Epstein-Barr Virus Latent Membrane Protein 1 (EBV LMP1))
-
Autre désignation
- Epstein-Barr Virus Latent Membrane Protein 1
-
Classe de substances
- Viral Protein
Antigène
-